U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675135) titled 'A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy' on June 22.
Brief Summary: This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-301 in treating excessive daytime sleepiness (EDS), cataplexy, sleepiness/wakefulness, and fatigue in adult participants (ages >=18 years) with narcolepsy.
Study Start Date: June 04
Study Type: INTERVENTIONAL
Condition:
EDS
Cataplexy
Fatigue
Narcolepsy
Intervention:
DRUG: HBS-301
HBS-301 tablet
OTHER: Placebo
Placebo tablet
Recruitment Status: RECRUITING
Sponsor: Harmony ...